Roderick C N van den Bergh1,2, Theo H van der Kwast3, Jeroen de Jong4, Homayoun Zargar5,6, Andrew J Ryan7, Anthony J Costello5, Declan G Murphy5,6, Henk G van der Poel4. 1. Royal Melbourne Hospital, Melbourne, Vic., Australia. roodvdb@hotmail.com. 2. Peter MacCallum Cancer Centre, Melbourne, Vic., Australia. roodvdb@hotmail.com. 3. Princess Margaret Cancer Center, University Health Network, Toronto, Canada. 4. Netherlands Cancer Institute, Amsterdam, The Netherlands. 5. Royal Melbourne Hospital, Melbourne, Vic., Australia. 6. Peter MacCallum Cancer Centre, Melbourne, Vic., Australia. 7. TissuPath Specialist Pathology, Vic., Australia.
Authors: R Mathieu; M Moschini; B Beyer; K M Gust; T Seisen; A Briganti; P Karakiewicz; C Seitz; L Salomon; A de la Taille; M Rouprêt; M Graefen; S F Shariat Journal: Prostate Cancer Prostatic Dis Date: 2017-01-10 Impact factor: 5.554
Authors: K R Beckmann; A D Vincent; M E O'Callaghan; P Cohen; S Chang; M Borg; S M Evans; D M Roder; K L Moretti Journal: BMC Cancer Date: 2017-08-10 Impact factor: 4.430
Authors: Lars Egevad; Brett Delahunt; David G Bostwick; Liang Cheng; Andrew J Evans; Troy Gianduzzo; Markus Graefen; Jonas Hugosson; James G Kench; Katia R M Leite; Jon Oxley; Guido Sauter; John R Srigley; Pär Stattin; Toyonori Tsuzuki; John Yaxley; Hemamali Samaratunga Journal: BJU Int Date: 2020-11-27 Impact factor: 5.588